Evidence map›Paper›PMID 38543819›Full record

ArticleViruses2024

Clinical Manifestations of Infections with the Omicron Sub-Lineages BA.1, BA.2, and BA.5: A Retrospective Follow-Up Analysis of Public Health Data from Mecklenburg-Western Pomerania, Germany.

Katja Verena Goller, Janine Ziemann, Christian Kohler, Karsten Becker, Nils-Olaf Hübner, On Behalf Of The CoMV-Gen Study Group

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Katja Verena GollerCentral Unit for Infection Prevention and Control and Institute for Hygiene and Environmental Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
Janine ZiemannCentral Unit for Infection Prevention and Control and Institute for Hygiene and Environmental Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
Christian KohlerFriedrich-Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, 17475 Greifswald, Germany.
Karsten BeckerFriedrich-Loeffler-Institute of Medical Microbiology, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-6391-1341
Nils-Olaf HübnerCentral Unit for Infection Prevention and Control and Institute for Hygiene and Environmental Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
On Behalf Of The CoMV-Gen Study Group
Universitätsmedizin Greifswald · DEFriedrich-Loeffler-Institut · DE

Funding

Ministry of Social Affairs, Health and Sports of the Federal State Government of Mecklenburg-Western Pomerania, Germany MV-Schutzfonds, grant number: 0680 894.01 MG 80
6 · The paper itself

Abstract

The Omicron variants BA.1, BA.2, and BA.5 caused several waves of SARS-CoV-2 in Germany in 2022. In this comparative study, public health data on SARS-CoV-2 infections from Mecklenburg-Western Pomerania, Germany, between January and October 2022 were examined retrospectively using Pearson's chi-squared tests and Fisher's exact tests for testing for statistical significance. Compared to BA.5 infections, BA.1 and BA.2 infections affected younger individuals aged up to 19 years significantly more often, whereas BA.5 infections occurred significantly more frequently in patients between 40 and 59 years of age when compared to BA.1 and BA.2. Infections with all three variants predominantly caused flu-like symptoms; nevertheless, there were significant differences between the reported symptoms of BA.1, BA.2, and BA.5 infections. Especially, the symptoms of 'fever', 'severe feeling of sickness', 'loss of taste', and 'loss of smell' were significantly more often present in patients with BA.5 infections compared to BA.1 and BA.2 cases. Additionally, BA.2 and BA.5 cases reported significantly more often the symptoms of 'runny nose' and 'cough' than BA.1-infected cases. Our findings indicate remarkable differences in the clinical presentations among the sub-lineages, especially in BA.5 infections. Furthermore, the study demonstrates a powerful tool to link epidemiological data with genetic data in order to investigate their potential impact on public health.

Indexed as

COVID-19Public HealthAgedFollow-Up StudiesGermanyHumansRetrospective StudiesBA.1BA.2BA.5COVID-19GermanyMecklenburg-Western PomeraniaOmicronpandemicSARS-CoV-2surveillancesymptoms

Identifiers

PMID38543819
PMCPMC10974208
OpenAlexW4392845103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.